RX RXRX $3.40 ▲ +1.80% Should I Buy Recursion Pharmaceuticals (RXRX)? Finance YouTuber Analysis
VERDICT: BUY 0/100
Get weekly updates on this stock
“The YouTuber recommends Recursion Pharmaceuticals, an AI stock aiming to revolutionize drug discovery by using language models and AI to accelerate…”
Financials
Reported figures · last 5 yearsCall record — RXRX
17 CALLS · 3 BUY / 1 SELL / 1 WATCHCreate a free account to see every call — who, when, at what price.
Each call is dated, linked to the source video, and graded. Free accounts see the full record.
FAQ
Should I buy Recursion Pharmaceuticals?
5 finance YouTubers analysed Recursion Pharmaceuticals with qualified reasoning — consensus: Buy, average analysis quality 68/100. This is not financial advice; review the individual analyses and sources above.
Are finance YouTubers bullish or bearish on Recursion Pharmaceuticals?
Among the channels covering Recursion Pharmaceuticals, 3 are buying and 1 are selling or avoiding — overall Buy.
What price target do YouTubers give Recursion Pharmaceuticals?
The price targets mentioned for Recursion Pharmaceuticals range 10–40. Targets are the YouTubers' own; not a guarantee.
How do you decide what to include for Recursion Pharmaceuticals?
Only qualified analyses count: a clear buy/sell stance on Recursion Pharmaceuticals with real reasoning (valuation, fundamentals, a catalyst or a chart setup). Passing mentions are excluded.